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INTRODUCTION  
Free radicals are small, highly reactive, molecules 
that are naturally generated in small amounts during the 
body’s metabolic reactions and can react with and damage 
complex cellular molecules such as fat, protein or DNA. 
The potential toxicity of free radicals is counteracted by a 
large number of cytoprotective enzymes and antioxidants 
that limit the damage. This protective mechanism 
functions co-operatively in form of a cascade in which 
antioxidants α-tocopherol, ascorbic acid and reduced 
glutathione act in combination.
1
 A homeostasis between 
rate of formation of free radicals and the rate of their 
neutralization if not maintained, oxidative damage 
accumulates, known as Oxidative Stress.
2
 
The liver plays a central and critical biochemical 
role in the metabolism, digestion, detoxification and 
elimination of substance from the body. Products derived 
from digestion of food are processed, transformed and 
stored in the liver. It is also the main site of metabolism of 
exogenous compounds, such as drugs and toxins.
3
 While 
there are many causes of liver disease, they generally 
present clinically in a few distinct patterns, usually 
classified as hepatocellular, Cholestatic (Obstructive) or 
mixed.
4
 However all aetiologies lead to liver damage that 
ranges from acute hepatitis to hepatocellular carcinoma, 
through many inflammatory processes, apoptosis, necrosis, 
fibrosis that involve hepatocyte, Kupffer, stellate and 
endothelial cells. Any insult to the liver cells produce 
reactive oxygen and nitrogen species (ROS, RNS), which 
in turn, is responsible for the induction and progression of 
liver disease, independent of its aetiology. These free 
radicals are involved in the transcription and activation of 
a large series of cytokines and growth factors that, in turn, 
can contribute to further production of ROS and RNS.
5
 
Thus the vicious cycle continues. The extent of cellular 
damage is manifested by either an increase in the oxidation 
products or a decrease in the antioxidant levels or both in 
our body. Hence by measuring the oxidative stress 
parameters, the extent of liver damage can be assessed. 
Globally, many people are addicted to alcoholism 
resulting in significant number of people suffering from 
alcoholic liver diseases. The number of people infected 
with Hepatitis B virus infection, all over the world, is also 
on the rise. Both the forms of hepatitis lead to hepatic 
damage of varying intensity, ranging from mild hepatitis to 
gross hepatic failure. Although a lot of information is 
available regarding the biochemical changes and Oxidative 
Stress Parameters in Alcohol Induced Hepatitis (chemical 
injury) and Hepatitis B virus infection (biological injury) 
separately, but a comparative evaluation of the above 
mentioned parameters is lacking. The present study was 
undertaken to note if any difference in the extent of 
oxidative stress caused by chemical and biological agents 
responsible for hepatitis exists and these tools may further 
be used as markers in determining extent of the disease 
and guide to the appropriate intervention to be taken in 
time.  
ABSTRACT 
The liver has a critical role in metabolism, digestion, detoxification and elimination of substances from the body. Hence in 
diseased conditions, the products of free radicals from the liver increase which results in further damage to the vital organs. 
This study is done to compare the oxidative stress parameters in hepatitis B virus infected patients and alcoholic hepatitis 
patients. The study included 150 individuals (39 females) aged 25-75years of which the Group A included   normal healthy 
volunteers; Group B consisted of alcoholic hepatitis patients and Group C included hepatitis B patients. When compared to 
control, Erythrocyte MDA was significantly high and erythrocyte GSH was significantly low in both Group B and Group C 
whereas Plasma Ascorbic Acid level & Serum α-Tocopherol were low in both the groups.  When group B and Group C were 
compared, MDA and GSH showed no significant difference (p>0.05) while α-Tocopherol and ascorbic acid levels varied 
significantly (p< 0.005).The liver enzymes were also significantly raised in both forms of Hepatitis, when compared to the 
control. The AST/ALT ratio was reversed (>1) in Group B (Alcoholic Hepatitis) as compared to Group C (Hepatitis B) and 
normal individuals (<1).  It is suggested that GSH, MDA in erythrocyte, Plasma Ascorbic Acid & Serum α-Tocopherol can be 
made an effective tool in assessing the progression of the liver disease for timely intervention. 
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MATERIALS AND METHODS 
This prospective study was undertaken by 
department of Biochemistry, Medical College, Kolkata 
between January 2012 to December 2012. Permission of 
the Institutional Ethics Committee was obtained. A 
preliminary screening of Study subjects was done from the 
Medicine out patients department of the Institution. 
Subjects diagnosed to be suffering from Alcohol induced 
hepatitis and Hepatitis B were selected for the study. A 
total of 150 subjects (age 25-75 years of either sex) were 
enrolled into the study.  Group A consisted of 50 healthy 
volunteers and acted as control.  Group B consisted of 50 
clinically proven alcoholic hepatitis patients while Group 
C consisted of 50 clinically and serologically proven cases 
of Hepatitis B patients. 
Inclusion Criteria  
Group A (Healthy volunteers) 
1. Age 25-75years 
2. Free of any disease as per routine clinical, 
biochemical and microbiological Examination 
3. Non smoker  
4. Non alcoholic 
Group B (Alcoholic Hepatitis) 
1. Age 25-75years 
2. History of regular alcohol intake for at least 2 years  
3. Clinical features of Alcoholic hepatitis 
4. Laboratory findings of Alcoholic hepatitis 
5. No other disease apart from disease under study 
Group C (Hepatitis B) 
1. Age 25-75years 
2. Clinical features of Viral  hepatitis 
3. Laboratory findings correlating to Viral  hepatitis  
4. Serological tests positive for Hepatitis B 
5. No other disease apart from disease under study 
Exclusion criteria 
Group A:  
1. Alcoholics,  
2. Patients on chronic drug therapy  
3.  Patients suffering from any other disease  
Group B:  
1. Patients on chronic drug therapy,  
2.  Patients suffering from any other disease apart from 
alcoholic Hepatitis,  
3. Hepatitis due to any other cause apart from alcoholic 
Hepatitis. 
Group C: 
1.  Patients on chronic drug therapy, 
2. Hepatitis due to any cause other than Hepatitis B,  
3. Patients suffering from any other disease apart from 
Hepatitis B.  
Methods 
About 5ml of venous blood sample was taken 
from all the subjects under aseptic precautions. Of the 5ml 
of blood sample, 2.5 ml was collected in EDTA containing 
tubes for analysis of erythrocytic Glutathione (GSH), 
erythrocytic (MDA) and plasma ascorbic acid and the 
remaining 2.5 ml in plain vacutainers for analyzing Liver 
Enzymes and α-tocopherol. 
Preparation of blood for analysis 
Blood sample from the anticoagulant containing 
vacutainer was centrifuged at 3000rpm for 10 minutes; 
supernatant plasma was used for ascorbic acid estimation. 
The buffy coat was discarded. The packed cells were 
suspended in equal volume of cold phosphate buffer saline 
and re-centrifuged. The supernatant was discarded. The 
washing of packed cells was repeated twice, the packed 
cells were used for analysis of GSH and MDA.
6
 The blood 
sample from plain vacutainers was centrifuged at 3000 
rpm for 10 minutes; the serum was aspirated and was 
further used for analyzing liver enzymes and α-tocopherol. 
The Oxidative Stress Parameters that were assayed 
included: 
 Erythrocyte Glutathione (GSH) was estimated by 
DTNB method. 
 Malondialdehyde (MDA) in Erythrocyte was 
evaluated by measuring the Thiobarbituric Acid 
reacting substances (TBARs). 
 Plasma Ascorbic Acid was estimated by DNPH 
method. 
 Serum α-tocopherol was estimated by Baker and 
Flank method.    
The Liver Function Tests taken up for study: 
 Aspartate Amino Transferase (AST)  
 Alanine Amino Transferase (ALT)  
 Gamma Glutamyl Transferase (GGT)  
 Alkaline Phosphatase (ALP)  
The above were measured by using standard methods 
adapted in the clinical laboratory. 
Statistical analysis 
The values of all parameters were statistically analyzed 
using SPSS 15.0 software. A comparison of the mean 
values of oxidative stress parameters and liver enzymes 
were done separately between group A and B, Group A 
and C, group B and C using independent t test.  
RESULTS 
Table 1 shows the mean ± S.D of Erythrocyte Glutathione 
(GSH), Erythrocyte Malondialdehyde (MDA), Serum α-
tocopherol and Plasma Ascorbic Acid in Group A as 
11.94±1.86, 8.67± 1.29, 8.72±2.75, 1.14±0.21 
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respectively; Group B were 6.99 ±2.02, 12.43± 2.01, 
5.41±1.93, 0.92±0.23 respectively and Group C were 
7.69±2.13, 12.42±2.18, 8.23± 2.45 and 1.07 ± 0.19 
respectively. When compared to control, Erythrocyte GSH 
was significantly low and MDA was significantly high in 
both groups B & C (p<0.005). Plasma Ascorbic acid and 
Serum α-tocopherol levels were decreased in both the 
groups B & C when compared to Group A but was  
significantly low (p<0.005) only in group B (alcoholic 
hepatitis). 
 
Table 1: Comparison of Oxidative stress parameters in group A (Control), group B (Alcoholic Hepatitis) and group C 
(Hepatitis B); Results expressed as Mean ± SD 
 
Table 2 depicts the measure of liver enzymes. 
Mean ± S.D of serum Aspartate Transaminase (AST) in 
groups A, B and C was 28.12 ±10.21, 182.36 ± 96.14, 
240.1 ±192.40 respectively; serum Alanine Transaminase 
(ALT) were 32.40 ±11.90, 147.70 ±95.98, 297.50 ±221.3 
respectively; serum Alkaline Phosphatase(ALP) was 
150.84± 41.49, 279.24 ±120.97,248.84 ±91.78respectively 
and Gamma Glutamyl Transferase (GGT) 25.38 ±13.63, 
138.84 ±67.12, 72.42 ±of 42.61respectively.  The ratio of 
AST/ALT was 0.96±0.5, 1.38±0.37 and 0.81±0.18 
respectively. Liver enzymes showed high significance 
(p<0.005) in group B and C patients when compared 
individually with group A.  When we compared between 
Groups B and C serum AST and GGT showed significant 
change (p<0.005) where as changes of serum ALT and 
ALP were insignificant (p>0.05). 
 
Table 2: Comparison of liver enzymes in group A (Control), group B (Alcoholic Hepatitis) and group C (Hepatitis B); 
Results expressed as Mean ± SD 
 
DISCUSSION 
Free radical mediated damage to macromolecule 
plays a crucial role in the pathophysiology of 
atherosclerosis, inflammation, carcinogenesis, ageing, drug 
reactions and toxicity.
7
 Liver injury due to acute and 
chronic abuse has been proved to be dependent on its 
oxidative metabolism at the cytosolic, peroxisomal and/or 
microsomal levels. 
The present study showed that in the control 
group which included normal, healthy individuals; 
Oxidative stress parameters which included Glutathione 
(GSH), Malondialdehyde (MDA), α- Tocopherol and 
Ascorbic Acid were found to be in the considered normal 
range, which was concurring with the data from other 
studies.
 8, 9
  
The present study revealed that the patients 
suffering from liver disease either due Hepatitis B virus 
infection or excessive alcohol intake showed significant 
depletion (p < 0.005) of GSH level when compared with 
controls, which is similar to the findings from other 
studies.
10
 Several factors contribute to the fall in GSH 
level. Most important is oxidative stress, which consumes 
GSH. Depletion of GSH renders the cell more susceptible 
to oxidative stress.
11
 Decreased Glutathione Reductase 
(GR) activity may be predominant cause of GSH depletion 
within RBC leading to serious consequences like increased 
lipid peroxidation and haemolysis.
10
 The other reasons for 
GSH depletion being, it acts as a co-factor for Glutathione 
Transferase (GST) during detoxification of xenobiotics 
including alcohol and also suppression of glutathione 
synthesis by ethanol.
 12, 13
 However, when compared 
between group B and C, the mean values of GSH showed 
no significance (p>0.05).  
Results also revealed a significant rise (p<0.005) 
in the MDA levels in both group B and group C patients 
compared to group A, which is well in term with other 
Groups 
(n=50) 
Glutathione (mg/gm 
Hb) 
MDA 
(nmoles /gm Hb) 
α- Tocopherol 
(mg/l) 
Ascorbic Acid 
(mg/dl) 
GroupA 11.94 ± 1.86 8.67 ± 1.29 8.72 ± 2.75 1.14 ± 0.21 
GroupB 6.99 ± 2.02 12.43 ± 2.01 5.41± 1.93 0.92 ± 0.23 
Group C 7.69 ± 2.13 12.42 ± 2.18 8.23± 2.45 1.07 ± 0.19 
Gr A Vs Gr B p < 0.005 p < 0.005 p < 0.005 p < 0.005 
Gr A Vs Gr C p < 0.005 p < 0.005 p >0.05 p >0.05 
Gr B Vs Gr C p >0.05 p >0.05 p < 0.005 p< 0.005 
Groups (n=50) AST (IU/L)   ALT (IU/L)   AST/ALT ALP (IU/L)   GGT(U/L) 
Group A 28.12 ± 10.21 32.4 ± 11.9 0.96± 0.5 150.84 ± 41.49 25.38±13.63 
Group B 182.36 ± 96.14 147.7± 95.98 1.38± 0.37 279.24 ± 120.97 138.84±67.12 
Group C 240.1± 192.4 297.5 ± 221.3 0.81± 0.18 248.84 ± 91.78 72.42±42.61 
Gr A vs Gr B p < 0.005 p < 0.005 p < 0.005 p < 0.005 p < 0.005 
Gr A vs Gr C p < 0.005 p < 0.005 p < 0.005 p < 0.005 p < 0.005 
Gr B vs Gr C p >0.05 p < 0.005 p < 0.005 P >0.05 p < 0.005 
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studies.
5
 The raised MDA level reflects the oxidative 
injury due to alcohol and hepatitis B virus infection, which 
is attributed to free radical formation that subtracts 
hydrogen atoms from lipoproteins causing lipid 
peroxidation, of which MDA is the main product. But the 
levels of MDA did not vary significantly (p>0.05) when 
compared in group B and group C cases. 
The study revealed that although α- Tocopherol 
levels decreased significantly (p<0.005) in alcoholic 
hepatitis, they showed a slight decrease (p>0.05) in 
patients with Hepatitis B infection.
14
 
Another relevant finding in the study was that the 
Ascorbic Acid levels were significantly lowered (p<0.005) 
in Alcoholic patients compared to controls, but the levels 
were insignificantly reduced (p>0.05) in case of Hepatitis 
B virus infection. These results corroborated well with 
previous studies.
 10,13
 However, a comparison of the 
Ascorbic Acid levels in group B and group C, showed high 
significance (p<0.005). The possible explanation for this is 
that apart from the free radicals mediated depletion of 
ascorbic acid in hepatitis, alcohol directly reduces ascorbic 
acid levels in blood by impairing its absorption by 
damaging cell lining the stomach and intestines thus  
disabling transport into the blood and also by altering 
Vitamin C metabolism and utilization.
15,16, 17
 
The measure of liver enzymes revealed a 
significant rise in the levels of AST (p<0.005), ALT 
(p<0.005), ALP (p<0.005) and GGT (p<0.005) in both 
Hepatitis B virus infection and Alcoholics, compared to 
controls which also confirms the literature evidence.
 18, 19, 20
 
The AST/ALT ratio was found to be <1 in controls as well 
in Hepatitis B, but >1 in Alcoholic Hepatitis patients. This 
reversal of AST/ALT ratio in Alcoholic Hepatitis patients 
is correlating with previous studies.
20,21 
This is due to 
release of mitochondrial AST by alcohol itself or through 
its toxicity by its metabolites and/or oxidative stress
21
 
While  in Hepatitis B, ALT is typically higher than AST 
because of slower clearance.
5
 
This study substantiates a certain degree of 
oxidative stress and free radicals mediated damage in both 
Alcoholic Hepatitis and Hepatitis B virus infection. Earlier 
authors like Albano et al have postulated in their study that 
the generation of ethanol-derived free radicals, in 
alcoholism, is mainly due to the increased activity of 
cytochrome P-450 dependent monoxygenase system 
(cytochrome P-450 2E1).
22
 The first breakdown product, 
acetaldehyde initiates much of the inflammation and 
fibrosis in alcoholic hepatitis. Acetaldehyde and lipid 
peroxidation products recruit leukocytes, resulting in 
production of more inflammatory cytokines. This elicits a 
vicious cycle of inflammation that culminates in fibrosis 
and loss of hepatocytes.
23
 Thus hepatic ethanol overload is 
followed both by an increase in reactive oxygen species 
and by a decline of antioxidants. Obviously the latter can 
further deteriorate once lipid peroxidation has been 
stimulated. Researchers Rahamani et al and Waris et al in 
their works have shown that in Hepatitis B virus infection, 
HBx, the X gene product of Hepatitis B Virus genome, 
interacts with an outer mitochondrial voltage-dependent 
anion channel(VDAC3) and that this association leads to a 
decrease in the mitochondrial membrane potential and 
causes elevation of Reactive Oxygen Species.
 24, 25
 
It was seen that the extent of damage caused due 
to oxidative stress was similar in both chemically and 
biologically induced hepatitis patients. Thus it can be 
recommended that further supplementation of antioxidants, 
along with other treatment modalities can yield better 
results and improve the prognosis of the patients.  
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